title: [Cancers of the cavum].
abstract: Nasopharyngeal carcinoma (NPC) is a clinical entity different from other epidermoid carcinomas of the head and neck. It is distinguished by its particular histology, its geographic distribution, its special serologic and biologic relationship to Epstein-Barr Virus (EBV); its natural history NPC occurs more frequently in young men (25-40 years). NPC is one of the most aggressive tumors of the head and neck with a very high rate of cervical nodes and systemic dissemination. It is a very sensitive tumour and chemo-radiotherapy provides an excellent local efficiency (80%); the 5 years survival rates is about 50%.
authors.affiliation: Service ORL Institut Gustave-Roussy, Villejuif.
authors.forename: P
authors.initials: P
authors.lastname: Marandas
authors.forename: N
authors.initials: N
authors.lastname: Marandas
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D009362:Neoplasm Metastasis; D011879:Radiotherapy Dosage; D013997:Time Factors; D014057:Tomography, X-Ray Computed
chemical_list: D000970:Antineoplastic Agents